Back to top
more

Healthways, Inc. (TVTY)

(Delayed Data from NSDQ)

$22.85 USD

22.85
758,329

+0.75 (3.39%)

Updated May 3, 2019 04:00 PM ET

After-Market: $22.85 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Tivity Health (TVTY) Q1 Earnings and Revenues Lag Estimates

by Zacks Equity Research

Tivity Health (TVTY) delivered earnings and revenue surprises of -4.76% and 4.28%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Surgery Partners (SGRY) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

Surgery Partners (SGRY) delivered earnings and revenue surprises of -80% and 2.87%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

NovoCure (NVCR) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

NovoCure (NVCR) delivered earnings and revenue surprises of 76.47% and 1.25%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Tivity Health (TVTY) Moves 5.2% Higher: Will This Strength Last?

by Zacks Equity Research

Tivity Health (TVTY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Is Tivity Health (TVTY) a Suitable Stock for Value Investors?

by Zacks Equity Research

Let's see if Tivity Health, Inc. (TVTY) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.

Tivity Health (TVTY) Lags Q4 Earnings Estimates

by Zacks Equity Research

Tivity Health (TVTY) delivered earnings and revenue surprises of -21.05% and 0.60%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Icon PLC (ICLR) Q4 Earnings Meet Estimates

by Zacks Equity Research

Icon PLC (ICLR) delivered earnings and revenue surprises of 0% and 0.81%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Tivity Health (TVTY) Q4 Earnings Preview: What's in the Cards?

by Zacks Equity Research

Tivity Health (TVTY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Are These Medical Stocks a Great Value Stocks Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Tivity Health (TVTY) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

by Zacks Equity Research

Tivity Health (TVTY) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

Should Value Investors Buy These Medical Stocks?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

TVTY or DOCS: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

TVTY vs. DOCS: Which Stock Is the Better Value Option?

Tivity Health (TVTY) Q3 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Tivity Health (TVTY) delivered earnings and revenue surprises of 16.67% and 3.18%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Tivity Health (TVTY) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Tivity Health (TVTY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Tivity Health (TVTY) Surpasses Q2 Earnings and Revenue Estimates

by Zacks Equity Research

Tivity Health (TVTY) delivered earnings and revenue surprises of 37.14% and 6.89%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

6 GARP Stocks to Scoop Up for Maximum Returns

by Zacks Equity Research

If you're looking for a profitable portfolio of stocks that will offer the best of value and growth investing, try the growth at a reasonable price or GARP strategy.

Icon PLC (ICLR) Soars to 52-Week High, Time to Cash Out?

by Zacks Equity Research

Icon PLC (ICLR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Analysts Estimate Tivity Health (TVTY) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Tivity Health (TVTY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Avantor, Inc. (AVTR) Hits Fresh High: Is There Still Room to Run?

by Zacks Equity Research

Avantor, Inc. (AVTR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks.com featured highlights include: Home Depot, Tivity Health, Landstar System and Union Pacific

by Zacks Equity Research

Zacks.com featured highlights include: Home Depot, Tivity Health, Landstar System and Union Pacific

Shilpa Mete headshot

Add These 4 GARP Stocks to Your Portfolio for Maximum Returns

by Shilpa Mete

Growth at a reasonable price or GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount.

Avantor, Inc. (AVTR) Soars to 52-Week High, Time to Cash Out?

by Zacks Equity Research

Avantor, Inc. (AVTR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Tivity Health (TVTY) Q1 Earnings and Revenues Top Estimates

by Zacks Equity Research

Tivity Health (TVTY) delivered earnings and revenue surprises of 37.93% and 9.54%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Tivity Health (TVTY) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

Tivity Health (TVTY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The Zacks Analyst Blog Highlights: iRobot, Microsoft, Apple, NVIDIA and Tivity Health

by Zacks Equity Research

The Zacks Analyst Blog Highlights: iRobot, Microsoft, Apple, NVIDIA and Tivity Health